DaVita, Inc. (DVA) Tops Q4 EPS by 25c

Go back to DaVita, Inc. (DVA) Tops Q4 EPS by 25c

Goldman Sachs Downgrades DaVita (DVA) to Neutral

February 15, 2013 6:57 AM EST

Goldman Sachs downgraded DaVita (NYSE: DVA) from Buy to Neutral with a price target of $120 saying the stock is fairly valued and they see more upside elsewhere.

"While our outlook for core dialysis remains solid and we continue to see strong long-term growth... More